Published in Bone Marrow Transplant on January 01, 2005
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Oral manifestations in transplant patients. Dent Res J (Isfahan) (2015) 0.91
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
Emerging stem cell therapies: treatment, safety, and biology. Stem Cells Int (2012) 0.83
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study. Br J Cancer (2014) 0.79
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. Biol Blood Marrow Transplant (2016) 0.79
Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation. Radiat Oncol (2015) 0.78
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update. J Ovarian Res (2016) 0.76
Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. Children (Basel) (2015) 0.75
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia (2008) 3.58
Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr (1988) 2.62
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer (2006) 2.23
The adsorption of divalent cations to phosphatidylglycerol bilayer membranes. Biochim Biophys Acta (1981) 2.23
Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? Clin Oncol (R Coll Radiol) (2004) 2.12
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07
Interacting cell populations affecting granulopoietic colony formation by normal and leukemic human marrow cells. Blood (1973) 1.99
Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood (1978) 1.96
Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts. Blood (1979) 1.88
Lineage infidelity in acute leukemia. Blood (1983) 1.74
A rapid infusion protocol is safe for total dose iron polymaltose: time for change. Intern Med J (2011) 1.70
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa. Ann Oncol (2008) 1.67
The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. Blood (1987) 1.61
Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol (2002) 1.56
Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer (2006) 1.54
Direct medical costs attributable to osteoporotic fractures. Osteoporos Int (2002) 1.44
Connectedness versus separateness: applicability of family therapy to Japanese families. Fam Process (1992) 1.42
Ruptured intracranial dermoid cysts. Acta Neurochir (Wien) (2006) 1.41
Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem (2000) 1.38
Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature. Leuk Res (1999) 1.37
On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. Biochemistry (2000) 1.35
Identification of T lymphocytes in human mixed hemopoietic colonies. Blood (1981) 1.33
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus. Eur J Cancer (2006) 1.26
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. Br J Cancer (2006) 1.24
Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant (1997) 1.24
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study. Ann Oncol (2005) 1.23
The growth of large megakaryocyte colonies from human bone marrow. J Cell Physiol Suppl (1982) 1.20
MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins. Cancer Res (1999) 1.18
High-performance liquid chromatographic assay of chloramphenicol in serum. Antimicrob Agents Chemother (1978) 1.18
Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J Immunol (1987) 1.13
Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem (2000) 1.13
The protean manifestations of hemorrhagic fever with renal syndrome. A retrospective review of 26 cases from Korea. Ann Intern Med (1990) 1.11
MDM2 and MDMX can interact differently with ARF and members of the p53 family. FEBS Lett (2001) 1.10
A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood (1989) 1.09
Quinine for nocturnal leg cramps: a meta-analysis including unpublished data. J Gen Intern Med (1998) 1.08
Characterization of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascites tumor. Biochim Biophys Acta (1981) 1.08
Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs. Mol Cell Biol (1993) 1.07
Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease. Blood (1991) 1.06
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials. Ann Oncol (2013) 1.06
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet (1984) 1.06
Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. J Am Acad Dermatol (1988) 1.05
Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant (2004) 1.05
HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation (1999) 1.05
Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol (2001) 1.04
Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology (2006) 1.04
Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther (1993) 1.04
The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood (1982) 1.03
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease. Bone Marrow Transplant (2005) 1.03
Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials. Ann Oncol (2009) 1.03
Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. Proc Natl Acad Sci U S A (2000) 1.02
Cultural brokering in community health. Can Nurse (1999) 1.01
Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum. Biochem Biophys Res Commun (2000) 1.01
The role of working memory in analogical mapping. Mem Cognit (2000) 1.00
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value. Leukemia (2009) 1.00
Cell-to-cell interaction of Streptococcus sanguis and Propionibacterium acnes on saliva-coated hydroxyapatite. Infect Immun (1987) 1.00
Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature. Arch Intern Med (1990) 1.00
Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplant (2008) 1.00
Vascular events associated with alpha interferon therapy. Leuk Lymphoma (2003) 0.99
Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Ann Oncol (2004) 0.99
Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. Clin Genet (2011) 0.99
Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. J Natl Cancer Inst (1979) 0.98
Stimulatory activity for human pluripotent hemopoietic progenitors produced by a human T-lymphocyte cell line. Stem Cells (1981) 0.98
Structural studies of human alkyladenine glycosylase and E. coli 3-methyladenine glycosylase. Mutat Res (2000) 0.98
Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis (2002) 0.98
The decision to accept treatment for osteoporosis following hip fracture: exploring the woman's perspective using a stage-of-change model. Osteoporos Int (2002) 0.97
The effect of pregnancy and delivery on the function and ultrastructure of the rat bladder and urethra. BJU Int (2000) 0.97
A population-based study of tuberculosis epidemiology and innovative service delivery in Canada. Int J Tuberc Lung Dis (2012) 0.97
Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. DNA Cell Biol (1999) 0.96
Separation of different molecular forms of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells. Int J Cancer (1980) 0.96
Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006. Ann Oncol (2007) 0.95
Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int J Impot Res (2002) 0.95
A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis. Bone Marrow Transplant (2009) 0.94
The structure of the T cell gamma chain gene in lymphoproliferative disorders and lymphoma cell lines. Blood (1986) 0.94
Identification and regulation of human PDE5A gene promoter. Biochem Biophys Res Commun (2001) 0.94
A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. Eur J Cancer Care (Engl) (2007) 0.94
Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. J Med Genet (2011) 0.93
Properties of human pluripotent hemopoietic progenitors. Blood Cells (1980) 0.93
Nuclear magnetic resonance studies of the structure of model membrane systems: the effect of surface curvature. Ann N Y Acad Sci (1973) 0.93
Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Ann Oncol (2014) 0.93
Successful Nonsurgical Treatment of Pneumomediastinum, Pneumothorax, Pneumoperitoneum, Pneumoretroperitoneum, and Subcutaneous Emphysema following ERCP. Gastroenterol Res Pract (2010) 0.92
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia. Leukemia (2008) 0.92
Frequency of meiotic trisomy depends on involved chromosome and mode of ascertainment. Am J Med Genet (1999) 0.92
Placental haemozoin and malaria in pregnancy. Placenta (2000) 0.92
Systemic nocardiosis following allogeneic bone marrow transplantation. Transpl Infect Dis (2003) 0.91
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors. Am J Hematol (2013) 0.91
Women's perspectives on chronic illness: ethnicity, ideology and restructuring of life. Soc Sci Med (1991) 0.91
The heritable nature of clonal characteristics in acute myeloblastic leukemia. Blood (1981) 0.91
Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy. Ann Oncol (2009) 0.91
Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state. Am J Kidney Dis (1987) 0.90
Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site. Biochem Biophys Res Commun (2001) 0.90